Section Arrow
ALC.NYSE
- Alcon
Quotes are at least 15-min delayed:2026/01/01 05:00 EST
Regular Hours
Last
 78.81
-0.5 (-0.63%)
Day High 
79.4599 
Prev. Close
79.31 
1-M High
81.69 
Volume 
806.44K 
Bid
77.87
Ask
82
Day Low
78.53 
Open
79.42 
1-M Low
78.16 
Market Cap 
38.96B 
Currency 美元 
P/E 37.77 
%Yield 0.35 
10-SMA 79.86 
20-SMA 79.6 
50-SMA 77.5 
52-W High 99.2 
52-W Low 71.55 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.10/2.74
Enterprise Value
43.92B
Balance Sheet
Book Value Per Share
44.73
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
9.91B
Operating Revenue Per Share
18.50
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
AVTRAvantor11.46-0.01-0.09%11.55PE
BAXBaxter International19.11-0.19-0.98%140.32PE
WRBYWarby Parker21.79-0.23-1.04%-- 
EKSOEkso Bionics Holdings Inc8.64-1.94-18.34%-- 
XRAYDENTSPLY SIRONA11.43+0.03+0.26%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.